|
|
Blood, 15 September 2005, Vol. 106, No. 6, pp. 2156-2161.
Prepublished online as a Blood First Edition Paper on May 26, 2005; DOI 10.1182/blood-2005-02-0761.
Previous Article | Next Article 
Submitted February 23, 2005
Accepted May 16, 2005
A validated FISH trisomy index demonstrates the hyperdiploid and non-hyperdiploid dichotomy in MGUS
Wee J Chng*, Scott A Van Wier, Gregory J Ahmann, Jerry M Winkler, Syed M Jalal, P L Bergsagel, Marta Chesi, Mike C Trendle, Martin M Oken, Emily Blood, Kim Henderson, Rafael Santana-Davila, Robert A Kyle, Morie A Gertz, Martha Q Lacy, Angela Dispenzieri, Philip R Greipp, and Rafael Fonseca
Comprehensive Cancer Center and Division of Hematology and Oncology, Mayo Clinic Scottsdale, Scottsdale, AZ, USA
Division of Hematology, Mayo Clinic Rochester, Rochester, MN, USA
Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN, USA
Missouri Cancer Associates, Missouri, USA
North Memorial Cancer Center, Robbinsdale, MN, USA
Eastern Cooperative Oncology Group (ECOG) Statistical Center, Dana Farber Cancer Institute, Boston, MA, USA
* Corresponding author; email: chngwj{at}nuh.com.sg.
Two major genetic categories of multiple myeloma (MM) exist. Hyperdiploid MM (48 to 74 chromosomes, median 53 chromosomes) is associated with trisomies especially of chromosomes 3,7,9,11,15, and 19 while the non-hyperdiploid (less than 48 chromosomes or more than 74 chromosomes) MM is associated with primary translocations such as t(11;14), t(4;14) and t(14;16). Whether this dichotomy exist in MGUS is uncertain due to limitations of current methods in the study of ploidy. This is especially true in MGUS where the number of clonal plasma cells is small. In this study, we derived a FISH based trisomy index from pooled cytogenetic data (karyotype analysis) from 2 large cohorts of MM patients with abnormal karyotype and then validate it in 2 independent cohorts of patients who had known ploidy status either by karyotyping or DNA content measurement using flow cytometry. Using the criteria of 2 or more trisomies from a 3-chromosome combination, hyperdiploid myeloma can be detected with high specificity. Applying this index on 28 SMM/MGUS (11 SMM and 17 MGUS) patients who had normal karyotype, 11 hyperdiploid SMM/MGUS were detected. This percentage (40%) is remarkably similar to the percentage of hyperdiploid MM reported in the literature, suggesting that hyperdiploid MM may originate early during disease evolution.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
O. Landgren, L. R. Goldin, N. E. Caporaso, R. A. Kyle, and S. V. Rajkumar
Genetic Predisposition for Monoclonal Gammopathy of Undetermined Significance-reply-I
Mayo Clin. Proc.,
May 1, 2008;
83(5):
602 - 603.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bochtler, U. Hegenbart, F. W. Cremer, C. Heiss, A. Benner, D. Hose, M. Moos, J. Bila, C. R. Bartram, A. D. Ho, et al.
Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability
Blood,
May 1, 2008;
111(9):
4700 - 4705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Bink, E. Haralambieva, M. Kremer, G. Ott, C. Beham-Schmid, L. de Leval, S. C. Peh, H. R. Laeng, U. Jutting, P. Hutzler, et al.
Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics
Haematologica,
April 1, 2008;
93(4):
623 - 626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Brousseau, X. Leleu, J. Gerard, T. Gastinne, A. Godon, F. Genevieve, M. Dib, J.-L. Lai, T. Facon, M. Zandecki, et al.
Hyperdiploidy Is a Common Finding in Monoclonal Gammopathy of Undetermined Significance and Monosomy 13 Is Restricted to These Hyperdiploid Patients
Clin. Cancer Res.,
October 15, 2007;
13(20):
6026 - 6031.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Chng, S. Kumar, S. VanWier, G. Ahmann, T. Price-Troska, K. Henderson, T.-H. Chung, S. Kim, G. Mulligan, B. Bryant, et al.
Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling
Cancer Res.,
April 1, 2007;
67(7):
2982 - 2989.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Zhan, B. Barlogie, V. Arzoumanian, Y. Huang, D. R. Williams, K. Hollmig, M. Pineda-Roman, G. Tricot, F. van Rhee, M. Zangari, et al.
Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis
Blood,
February 15, 2007;
109(4):
1692 - 1700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Agnelli, S. Bicciato, S. Fabris, L. Baldini, F. Morabito, D. Intini, D. Verdelli, A. Callegaro, F. Bertoni, G. Lambertenghi-Deliliers, et al.
Integrative genomic analysis reveals distinct transcriptional and genetic features associated with chromosome 13 deletion in multiple myeloma
Haematologica,
January 1, 2007;
92(1):
56 - 65.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Zhan, Y. Huang, S. Colla, J. P. Stewart, I. Hanamura, S. Gupta, J. Epstein, S. Yaccoby, J. Sawyer, B. Burington, et al.
The molecular classification of multiple myeloma
Blood,
September 15, 2006;
108(6):
2020 - 2028.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. Rajkumar, A. Dispenzieri, and R. A. Kyle
Monoclonal Gammopathy of Undetermined Significance, Waldenstrom Macroglobulinemia, AL Amyloidosis, and Related Plasma Cell Disorders: Diagnosis and Treatment
Mayo Clin. Proc.,
May 1, 2006;
81(5):
693 - 703.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Chng, G. J. Ahmann, K. Henderson, R. Santana-Davila, P. R. Greipp, M. A. Gertz, M. Q. Lacy, A. Dispenzieri, S. Kumar, S. V. Rajkumar, et al.
Clinical implication of centrosome amplification in plasma cell neoplasm
Blood,
May 1, 2006;
107(9):
3669 - 3675.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Landgren, G. Gridley, I. Turesson, N. E. Caporaso, L. R. Goldin, D. Baris, T. R. Fears, R. N. Hoover, and M. S. Linet
Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States
Blood,
February 1, 2006;
107(3):
904 - 906.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|